Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov 13;22(11):e20032.
doi: 10.2196/20032.

Effects of Different Telemonitoring Strategies on Chronic Heart Failure Care: Systematic Review and Subgroup Meta-Analysis

Affiliations
Meta-Analysis

Effects of Different Telemonitoring Strategies on Chronic Heart Failure Care: Systematic Review and Subgroup Meta-Analysis

Hang Ding et al. J Med Internet Res. .

Abstract

Background: Telemonitoring studies in chronic heart failure are characterized by mixed mortality and hospitalization outcomes, which have deterred the uptake of telemonitoring in clinical practice. These mixed outcomes may reflect the diverse range of patient management strategies incorporated in telemonitoring. To address this, we compared the effects of different telemonitoring strategies on clinical outcomes.

Objective: The aim of this systematic review and subgroup meta-analysis was to identify noninvasive telemonitoring strategies attributing to improvements in all-cause mortality or hospitalization outcomes for patients with chronic heart failure.

Methods: We reviewed and analyzed telemonitoring strategies from randomized controlled trials (RCTs) comparing telemonitoring intervention with usual care. For each strategy, we examined whether RCTs that applied the strategy in the telemonitoring intervention (subgroup 1) resulted in a significantly lower risk ratio (RR) of all-cause mortality or incidence rate ratio (IRR) of all-cause hospitalization compared with RCTs that did not apply this strategy (subgroup 2).

Results: We included 26 RCTs (N=11,450) incorporating 18 different telemonitoring strategies. RCTs that provided medication support were found to be associated with a significantly lower IRR value than RCTs that did not provide this type of support (P=.01; subgroup 1 IRR=0.83, 95% CI 0.72-0.95 vs subgroup 2 IRR=1.02, 95% CI 0.93-1.12). RCTs that applied mobile health were associated with a significantly lower IRR (P=.03; IRR=0.79, 95% CI 0.64-0.96 vs IRR=1.00, 95% CI 0.94-1.06) and RR (P=.01; RR=0.67, 95% CI 0.53-0.85 vs RR=0.95, 95% CI 0.84-1.07).

Conclusions: Telemonitoring strategies involving medication support and mobile health were associated with improvements in all-cause mortality or hospitalization outcomes. These strategies should be prioritized in telemonitoring interventions for the management of patients with chronic heart failure.

Keywords: chronic heart failure; meta-analysis; mobile health; systematic review; telehealth; telemonitoring.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Flow diagram of study selection.
Figure 2
Figure 2
Risk of bias assessment. Authors' judgments about each methodological quality item are presented as percentages across all included studies.
Figure 3
Figure 3
Risk of bias summary. Authors' judgements about each risk of bias item are summarized for each included study.
Figure 4
Figure 4
Event counts and effectiveness of telemonitoring interventions on all-cause mortality. There were 20 randomized controlled trials (N=10,263) with mortality event counts in the subgroup meta-analysis. RR: relative risk.
Figure 5
Figure 5
Event counts and effectiveness of telemonitoring interventions on all-cause hospitalization. There were 24 randomized controlled trials (N=9612) with hospitalization event counts in the subgroup meta-analysis. IRR: incidence rate ratio.

Similar articles

Cited by

References

    1. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014 Sep 30;1(1):4–25. doi: 10.1002/ehf2.12005. - DOI - PubMed
    1. Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7–11. doi: 10.15420/cfr.2016:25:2. http://europepmc.org/abstract/MED/28785469 - DOI - PMC - PubMed
    1. Burnett H, Earley A, Voors AA, Senni M, McMurray JJ, Deschaseaux C, Cope S. Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis. Circ Heart Fail. 2017 Jan;10(1):e003529. doi: 10.1161/CIRCHEARTFAILURE.116.003529. http://europepmc.org/abstract/MED/28087688 - DOI - PMC - PubMed
    1. Riley JP, Masters J. Practical multidisciplinary approaches to heart failure management for improved patient outcome. Eur Heart J Suppl. 2016 Dec 06;18(suppl G):G43–G52. doi: 10.1093/eurheartj/suw046. - DOI
    1. Jeon Y, Kraus SG, Jowsey T, Glasgow NJ. The experience of living with chronic heart failure: a narrative review of qualitative studies. BMC Health Serv Res. 2010 Mar 24;10(1):77. doi: 10.1186/1472-6963-10-77. https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-10-77 - DOI - DOI - PMC - PubMed